Cargando…
Vitamin E Phosphate Nucleoside Prodrugs: A Platform for Intracellular Delivery of Monophosphorylated Nucleosides
Vitamin E phosphate (VEP) nucleoside prodrugs are designed to bypass two mechanisms of tumor resistance to therapeutic nucleosides: nucleoside transport and kinase downregulation. Certain isoforms of vitamin E (VE) have shown activity against solid and hematologic tumors and result in chemosensitiza...
Autores principales: | Daifuku, Richard, Koratich, Michael, Stackhouse, Murray |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874712/ https://www.ncbi.nlm.nih.gov/pubmed/29415423 http://dx.doi.org/10.3390/ph11010016 |
Ejemplares similares
-
Synthesis of Nucleoside Phosphate
and Phosphonate
Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014) -
Advances in antiviral nucleoside analogues and their prodrugs
por: Seley-Radtke, Katherine, et al.
Publicado: (2018) -
Nucleoside diphosphate and triphosphate prodrugs – An unsolvable task?
por: Meier, Chris
Publicado: (2017) -
NUC041, a Prodrug of the DNA Methytransferase Inhibitor 5-aza-2′,2′-Difluorodeoxycytidine (NUC013), Leads to Tumor Regression in a Model of Non-Small Cell Lung Cancer
por: Daifuku, Richard, et al.
Publicado: (2018) -
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery
por: Baroud, Milad, et al.
Publicado: (2021)